Literature DB >> 29093194

Distribution and function of the muscarinic receptor subtypes in the cardiovascular system.

Hannah C Saternos1, Daniyah A Almarghalani1, Hayley M Gibson1, Mahmood A Meqdad1, Raymond B Antypas1, Ajay Lingireddy1, Wissam A AbouAlaiwi1.   

Abstract

Muscarinic acetylcholine receptors belong to the G protein-coupled receptor superfamily and are widely known to mediate numerous functions within the central and peripheral nervous system. Thus, they have become attractive therapeutic targets for various disorders. It has long been known that the parasympathetic system, governed by acetylcholine, plays an essential role in regulating cardiovascular function. Unfortunately, due to the lack of pharmacologic selectivity for any one muscarinic receptor, there was a minimal understanding of their distribution and function within this region. However, in recent years, advancements in research have led to the generation of knockout animal models, better antibodies, and more selective ligands enabling a more thorough understanding of the unique role muscarinic receptors play in the cardiovascular system. These advances have shown muscarinic receptor 2 is no longer the only functional subtype found within the heart and muscarinic receptors 1 and 3 mediate both dilation and constriction in the vasculature. Although muscarinic receptors 4 and 5 are still not well characterized in the cardiovascular system, the recent generation of knockout animal models will hopefully generate a better understanding of their function. This mini review aims to summarize recent findings and advances of muscarinic involvement in the cardiovascular system.

Entities:  

Keywords:  blood pressure; endothelium/vascular type/nitric oxide; vascular biology

Mesh:

Substances:

Year:  2017        PMID: 29093194     DOI: 10.1152/physiolgenomics.00062.2017

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  10 in total

1.  Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice.

Authors:  Corinne G Jolivalt; Katie E Frizzi; May Madi Han; Andre J Mota; Lucie S Guernsey; Lakshmi P Kotra; Paul Fernyhough; Nigel A Calcutt
Journal:  J Pharmacol Exp Ther       Date:  2020-04-23       Impact factor: 4.030

2.  Immunomodulatory role of non-neuronal cholinergic signaling in myocardial injury.

Authors:  Cibele Rocha-Resende; Carla Weinheimer; Geetika Bajpai; Luigi Adamo; Scot J Matkovich; Joel Schilling; Philip M Barger; Kory J Lavine; Douglas L Mann
Journal:  JCI Insight       Date:  2019-06-04

Review 3.  Targeting the M1 muscarinic acetylcholine receptor in Alzheimer's disease.

Authors:  Louis Dwomoh; Gonzalo S Tejeda; Andrew B Tobin
Journal:  Neuronal Signal       Date:  2022-04-21

4.  Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive Targets.

Authors:  Rhéure Alves-Lopes; Karla B Neves; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2019-02-13       Impact factor: 5.223

5.  Choline Attenuates Cardiac Fibrosis by Inhibiting p38MAPK Signaling Possibly by Acting on M3 Muscarinic Acetylcholine Receptor.

Authors:  Lihui Zhao; Tingting Chen; Pengzhou Hang; Wen Li; Jing Guo; Yang Pan; Jingjing Du; Yuyang Zheng; Zhimin Du
Journal:  Front Pharmacol       Date:  2019-11-21       Impact factor: 5.810

Review 6.  Differential Actions of Muscarinic Receptor Subtypes in Gastric, Pancreatic, and Colon Cancer.

Authors:  Alyssa Schledwitz; Margaret H Sundel; Madeline Alizadeh; Shien Hu; Guofeng Xie; Jean-Pierre Raufman
Journal:  Int J Mol Sci       Date:  2021-12-05       Impact factor: 5.923

Review 7.  Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Authors:  Jaromir Myslivecek
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

8.  Dynamic monitoring of single-terminal norepinephrine transporter rate in the rodent cardiovascular system: A novel fluorescence imaging method.

Authors:  Lily L Cao; Andrew P Holmes; Janice M Marshall; Larissa Fabritz; Keith L Brain
Journal:  Auton Neurosci       Date:  2019-12-26       Impact factor: 3.145

Review 9.  Nitrosative Stress and Its Association with Cardiometabolic Disorders.

Authors:  Israel Pérez-Torres; Linaloe Manzano-Pech; María Esther Rubio-Ruíz; María Elena Soto; Verónica Guarner-Lans
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

10.  Pulmonary Microcirculation during Experimental Pulmonary Thromboembolism under Conditions of Activation and Blockade of Muscarinic Acetylcholine Receptors.

Authors:  V I Evlakhov; T P Berezina; I Z Poyassov; V I Ovsyannikov
Journal:  Bull Exp Biol Med       Date:  2021-06-26       Impact factor: 0.804

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.